500,000 COVID vaccine arrives in Sri Lanka | Daily News

500,000 COVID vaccine arrives in Sri Lanka

A consignment of 500,000 doses of Oxford-AstraZeneca vaccines ordered from the Serum Institute of India arrived in Sri Lanka this afternoon.

This is the first set of 10 million vaccines ordered from the Serum Institute of India by the State Pharmaceuticals Corporation (SPC).

 


Update: 

500,000 Covishield doses arrive:

First of SPC’s 10 million order from Serum Institute

Ishara Mudugamuwa

A consignment of 500,000 doses of Oxford-AstraZeneca vaccines ordered from the Serum Institute of India arrived in Sri Lanka yesterday afternoon.

This is the first set of 10 million doses ordered from the Serum Institute of India by the State Pharmaceuticals Corporation (SPC). The consignment of the vaccines was officially received by Pharmaceutical Production Supply and Regulation State Minister Prof. Channa Jayasumana at the Central Vaccine Store in Colombo.

The SPC had recently signed an order with Serum Institute of India (SII) for 10 million doses of the vaccine. This agreement was approved by the Attorney General last week.

In January, under India’s neighbourhood first policy, Sri Lanka received 500,000 doses of free vaccines. They were administered as a priority to frontline health workers and members of the Armed forces.

Oxford-AstraZeneca’s Covishield vaccine is being manufactured by the Pune-based Serum Institute. The SII has collaborated with Oxford University and pharmaceutical company AstraZeneca to make the vaccine.

Earlier this week, the vaccination was extended to the public and MPs. Over 350,000 out of 500,000 Oxford–AstraZeneca vaccines have been administered so far.

The government has decided to vaccinate 14 million people out of the total population of the country against the COVID-19 epidemic.

The Cabinet of Ministers this week granted their consent to the proposal submitted by the Acting Health Minister of Prof. Channa Jayasumana to take measures with regard to that decision.

Accordingly Cabinet approval has been granted to sign the Standardized Indemnification Agreement submitted by the COVAX mechanism in order to expedite the vaccination under the COVAX facility and to purchase Rs.10 million Oxford AstraZeneca vaccine for 52.5 million US dollars as a direct procurement from the Serum Institute of India.